Case Report: Successful treatment of late-onset immune checkpoint inhibitor-associated membranous nephropathy in a patient with advanced renal cell carcinoma

BackgroundDiagnosing immune checkpoint inhibitor (ICI)-associated nephritis can be challenging since it is a rare complication of therapy, associated with a spectrum of immune-mediated pathologies, and can present months after ICI therapy discontinuation (i.e., late-onset). ICIs are increasingly adm...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Praveen Ratanasrimetha, Vikas D. Reddy, Jaya Kala, Amanda Tchakarov, William F. Glass, Pavlos Msaouel, Jamie S. Lin
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2022-07-01
coleção:	Frontiers in Immunology
Assuntos:	immune checkpoint inhibitor (ICI) immune related adverse events (irAEs) membranous nephropathy (MN) proteinuria rituximab case report
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.898811/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!